Analysis of global intestinal nematode infections trends (1990-2021)
In 2021, the number of deaths related to intestinal nematode infections was 5,529 (95% UI: 4,323-6,774), with a corresponding ASMR of 0.08 per 100,000 people (95% UI: 0.06-0.10) (Fig 1A). The DALYs totaled 1,660,593, giving an ASDR of 22.43 per 100,000 (Fig 1B). The prevalence number was 773,734,280, with an ASPR of 10,037.02 per 100,000 (Fig 1C). During this period, all three burden indicators showed a consistent downward trend (Fig 1). Compared with 1990 levels, the number of deaths decreased by 77.0% (from 24,015), DALYs by 77.3% (from 7,324,965) and prevalent cases by 54.3% (from 1,692,210,617). The estimated annual percentage changes (EAPCs) were -5.12(95% CI: -5.20 to -5.04) for deaths, -5.65 (95% CI: -5.78 to -5.53) for DALYs and -3.59 (95% CI: -3.68 to -3.51) for prevalence, confirming a steady global reduction trend in the intestinal nematode infections over the three decades.
Subgroup analysis by age, gender, SDI, GBD and country in 2021
Across all age groups, the disease burden indicators, (the number of deaths, DALYs, ASMR and ASDR) peaked in the 0-5y age group and declined thereafter with increasing age. The highest prevalence and ASPR were observed in the 5-9 and 10-14 year age groups. In 2021, children aged <5 years group experienced 4,275 deaths (ASMR: 0.64) and 479,992 DALYs (ASDR: 71.87). The 5-9 y group had the highest prevalence with 117,969,072 cases (ASPR: 16,992.46) followed by the 10-14 y group with115,307,285 cases (ASPR: 17,207.82). In contrast, the ³95 y age group had the lowest disease burden with only 6 deaths and 273 DALYs. With regard to the gender, the disease burden indicators were comparable between females and males, with only minor variation in the number of deaths, DALYs, prevalence cases and ASRs.
Across SDI regions, in the low SDI region presented the highest disease burden indicators. In 2021, the low SDI region recorded 3,944 deaths (ASMR: 0.18), 930,815 DALYs (ASDR: 47.30) and 261,268,855 prevalent cases (ASPR: 14,391.15), which were substantially higher than the corresponding estimates in high SDI region and the high-middle SDI region.
At the regional level, Central Africa recorded highest ASMR (0.37), whereas Oceania had the highest ASDR (143.98) and ASPR (41,834.54) in 2021. However, the highest disease burden was noticed in World Bank Sub-Saharan Africa region that recorded 4,189 deaths and 867,465 DALYs, while World Bank Lower Middle Income region had the highest prevalence 363,930,749 cases). Among the GBD regions, Eastern Sub-Saharan Africa recorded 1,192 deaths and 328,794 DALYs, while Southeast Asia recorded 894 deaths and 335,001 DALYs. At the national level, intestinal nematode infections were widely distributed in 2021 globally, with casesreported from Africa, Asia and the Americas. The highest ASMR (0.99) and ASDR (238.48) was noticed in the Central African Republic while Peru recorded the highest ASPR (50,931.9). Nigeria had the highest number of deaths (1,065) and DALYs (173,304), while India reported the highest prevalence (116,071,255, cases). Other high-burden countries included the Democratic Republic of the Congo, Ethiopia and Indonesia. In contrast, many high-income countries (
e.g., United States, Germany, Japan) reported negligible deaths and prevalent cases, with GBD estimates rounding to zero.
Trend analysis and prediction of disease burden
From 1990 to 2021, all disease burden indicators showed an overall reduction trend across age, gender and SDI groups (Fig 2-4). Age-wise analyses showed that marked reductions in ASMR occured in children aged <5 years (EAPC: -5.38), whereas the smallest decline was noticed in individuals aged ≥95 years (EAPC: -0.83). The greatest decease in DALYs occurred in the 50-54 years age group (EAPC: -6.13). Similar reducing trend was observed in both males and females. Across SDI quintiles, the low SDI region experienced the largest reduction in ASMR (EAPC: -6.22), while the middle SDI region recorded the smallest decline(EAPC: -4.23).
At the regional and national levels, disease burden indicators decreased in most of the GBD regions and countries between 1990 and 2021 (Fig 5). East Asia experienced the grestest reduction in ASDR (EAPC: -11.16), whereas Oceania showed the smallest decline (EAPC: -1.79). Burkina Faso (and Ethiopia experienced the most rapid reduction in ASMR, while increasing trends were observed in a few countries and territories such as Zimbabwe and Vanuatu.
Forecast for 2022-2026 generated employing the ARIMA model indicated a gradual reduction in t ASMR, ASDR, ASPR, number of deaths, DALYs and prevalence (Figure 6A-C). Similar trends were obtained using the ES model (Fig 6D-F). However, the ARIMA model projected a substantially greater decline in the disease burden indicators, whereas the ES model predicted a more gradual decrease over the same projection period.
Utilizing the latest GBD 2021 data, the present study assessed the global burden of intestinal nematode infections from 1990 to 2021 and predicted the disease burden for the period from 2022 to 2046 using ARIMA and ES models. Both models predicted continued reduction in disease burden over the next two decades, supporting the reliability of future burden estimates and providing scientific evidence to inform long-term public health policy planning.
This reduction in the global burden of intestinal nematode infections is compatible with earlier studies disclosing considerable development progress in the control of neglected tropical diseases. The reduction in the disease burden may be attributable to multiple factors, including enhanced garbage and sewage treatment, promotion of sanitary toilets and tap water, interruption of transmission routes (
Cooper and Hollingsworth, 2018;
Chen et al., 2021) advanced diagnostic techniques and the widespread use of effective deworming drugs
(Chai et al., 2021; Jayakody et al., 2022;
Banas et al., 2025). Furthermore, community based health education campaigns and school based deworming programs have played a critical role in breaking the cycle of re-infection, particularly among children in endemic areas. At the global level, the disease burden indicators of intestinal nematode infections in low SDI regions have significantly decreased, thanks to multi-dimensional interventions. This trend reflects the improvement in the medical and health sector investment,
(Chen et al., 2021), implementation of regular large-scale deworming campaigns and strengthened collaboration between national governments and international health organization
(Hu et al., 2018). These combined efforts have continuously reduced the infection indicators. Despite these achievements, the residual burden in low SDI regions remains substantially higher than in other SDI quintiles, underscoring the need for sustained investment. Though, most countries and regions presented reducing trend, increasing trend in disease burden indicators were noticed in Southern Sub-Saharan Africa and Zimbabwe. This is likely to be due to the ecological conditions conducive for parasites transmission, weak health infrastructure, lack of public health education and insufficient understanding of the disease’s pathogenic mechanism, making it difficult to establish effective prevention mechanisms. This result is consistent with previous research conclusions
(Elliott et al., 1999; Pullan et al., 2010). Therefore, to achieve the goal of eliminating the public health threat of intestinal nematode infections globally, more investment and support should be provided to low SDI regions
(Bergquist et al., 2015). This study has the following limitations: 1. The GBD data mainly rely on the existing reports and underreporting or incomplete monitoring system, in resource limited areas may have resulted underestimation of disease burden
(Hotez et al., 2014). 2. Difference in diagnostic methods and reporting standards among countries may affect the comparability of data. 3. There is insufficient quantitative research on the long-term health impacts of intestinal nematode infections, such as impaired growth cognitive function impairment,
etc. Moreover, the GBD estimates may not fully capture co infections with other parasites, which could modify disease severity and treatment outcomes. Future studies integrating multi pathogen surveillance would further improve the accuracy of global disease burden assessments.